Advertisement

Immunopathology

  • Vladimir V. Klimov
Chapter

Abstract

The immune system can fall ill with some diseases such as primary immunodeficiencies, secondary immunocompromised conditions including HIV infection, allergic diseases, autoimmune/autoinflammatory disorders, and cancer. The immune system is responsible for graft rejection and/or survival. The reader can find the information on the development of diagnostic, therapeutic, and preventative strategies to combat this threat and an odd concept concerning atopic allergic conditions.

Supplementary material

466144_1_En_6_MOESM1_ESM.mp3 (10.4 mb)
(MP3 10614 kb)

Bibliography

Reviews

  1. Azizi G, Yazdani R, Mirshafiey A. Th22 cells in autoimmunity: a review of current knowledge. Eur Ann Allergy Clin Immunol. 2015;47(4):108–17.PubMedGoogle Scholar
  2. Bajic G, Degn SE, Thiel S, Andersen GR. Complement activation, regulation, and molecular basis for complement-related diseases. EMBO J. 2015;34(22):2735–57.CrossRefGoogle Scholar
  3. Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol. 2012;3:211.  https://doi.org/10.3389/fimmu.2012.00211.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Capalbo D, DeMartino L, Giardino G, et al. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: insights into genotype-phenotype correlation. Int J Endocrinol. 2012;353(250):1–9.  https://doi.org/10.1155/2012/353250.CrossRefGoogle Scholar
  5. De Luca DA, Bauer W, Galimberti RL. Innate Lymphoid Cells: the hidden actors in skin disorders. Clin Dermatol J. 2016;1(1):000101.Google Scholar
  6. Eifan AO, Durham SR. Pathogenesis of rhinitis. Clin Exp Allergy. 2016;46(9):1139–51.  https://doi.org/10.1111/cea.12780.CrossRefPubMedGoogle Scholar
  7. Ferreira MS, Borges AS. Some aspects of protozoan infections in immunocompromised patients - a Review. Mem Inst Oswaldo Cruz. 2002;97(4):443–57.  https://doi.org/10.1590/S0074-02762002000400001.CrossRefGoogle Scholar
  8. Fodil N, Langlais D, Gros P. Primary immunodeficiencies and inflammatory disease: a growing genetic intersection. Trends Immunol. 2016;37(2):126–40.  https://doi.org/10.1016/j.it.2015.12.006.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Fridlender ZG, Albelda SM. Tumor-associated neutrophils: friend or foe? Carcinogenesis. 2012;33(5):949–55.  https://doi.org/10.1093/carcin/bgs123.CrossRefPubMedGoogle Scholar
  10. Fucikova J, Moserova I, Urbanova L, et al. Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer. Front Immunol. 2015;6:402.  https://doi.org/10.3389/fimmu.2015.00402.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Ganapathy S, Vedam V, Rajeev V, Arunachalam R. Autoimmune disorders – immunopathogenesis and potential therapies. J Young Pharm. 2017;9(1):14–22.  https://doi.org/10.5530/jyp.2017.9.4.CrossRefGoogle Scholar
  12. Gao J, Zhao L, Wan YY, Zhu B. Mechanism of action of IL-7 and its potential applications and limitations in cancer immunotherapy. Int J Mol Sci. 2015;16:10267–80.  https://doi.org/10.3390/ijms160510267.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Ho JTK, Chan GCF, Li JCB. Systemic effects of gut microbiota and its relationship with disease and modulation. BMC Immunol. 2015;16(21):1–6.  https://doi.org/10.1186/s12865-015-0083-2.CrossRefGoogle Scholar
  14. Jacobsen EA, Helmers RA, Lee JJ, Lee NA. The expanding role(s) of eosinophils in health and disease. Blood. 2012;120(19):3882–90.  https://doi.org/10.1182/blood-2012-06-330845.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Krystel-Whittemore M, Dileepan KN, Wood JG. Mast cell: a multi-functional master cell. Front Immunol. 2016;6(620):1–12.  https://doi.org/10.3389/fimmu.2015.00620.CrossRefGoogle Scholar
  16. Kuwabara T, Ishikawa F, Kondo M, Kakiuchi T. The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediat Inflamm. 2017;2017(3908061):1–11.  https://doi.org/10.1155/2017/3908061.CrossRefGoogle Scholar
  17. Lee HY, Stieger M, Yawalkar N, Kakeda M. Cytokines and chemokines in irritant contact dermatitis. Mediat Inflamm. 2013;2013:916497, 1–7.  https://doi.org/10.1155/2013/916497.CrossRefGoogle Scholar
  18. Nassereddine S, Rafei H, Elbahesh E, Tabbara I. Acute graft versus host disease: a comprehensive review. Anticancer Res. 2017;37:1547–55.  https://doi.org/10.21873/anticanres.11483.CrossRefPubMedGoogle Scholar
  19. Raje N, Dinakar C. Overview of immunodeficiency disorders. Immunol Allergy Clin N Am. 2015;35(4):599–623.  https://doi.org/10.1016/j.iac.2015.07.001.CrossRefGoogle Scholar
  20. Robbins PD, Dorronsoro A, Booker CN. Regulation of chronic inflammatory and immune processes by extracellular vesicles. J Clin Invest. 2016;126(4):1173–80.  https://doi.org/10.1172/JCI81131.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Singh S, Sharma B. Immunodeficiency and microbial infections. J Micro Creat. 2015;1(102):1–5.Google Scholar
  22. Smolinska S, Jutel M, Crameri R, O’Mahony L. Histamine and gut mucosal immune regulation. Allergy. 2014;69:273–81.  https://doi.org/10.1111/all.12330.CrossRefPubMedGoogle Scholar
  23. Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy. 2014;2014:354250,1-7.  https://doi.org/10.1155/2014/354250.CrossRefGoogle Scholar

Landmark Papers

  1. Acharya A, Vaniawala S, Parekh H, Misra RN, Wani M, Mukhopadhyaya PN. Human immunodeficiency virus: discovery to drug resistance – a review update. Biol Syst Open Access. 2016;5(1000154):1–8.  https://doi.org/10.4172/2329-6577.1000154.CrossRefGoogle Scholar
  2. Bantz SK, Zhu Z, Zheng T. The Atopic March: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014;5(2):1–16.  https://doi.org/10.4172/2155-9899.1000202.CrossRefGoogle Scholar
  3. Gauthier M, Ray A, Wenzel S. Evolving concepts of asthma. Am J Respir Crit Care Med. 2015;192(6):660–8.  https://doi.org/10.1164/rccm.201504-0763PP.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Pali-Schöll I, Jensen-Jarolim E. The concept of allergen-associated molecular patterns (AAMP). Curr Opin Immunol. 2016;42:113–8.  https://doi.org/10.1016/j.coi.2016.08.004.CrossRefPubMedGoogle Scholar
  5. Pelaia G, Vatrella A, Busceti MT, et al. Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma. Mediat Inflamm. 2015;2015:879783.  https://doi.org/10.1155/2015/879783.CrossRefGoogle Scholar
  6. Warrington R, Watson W, Kim HL, Antonetti FR. An introduction to immunology and immunopathology. Allergy, Asthma Clin Immunol. 2011;7(1):1–8.  https://doi.org/10.1186/1710-1492-7-S1-S1.CrossRefGoogle Scholar

Suggested Reading

  1. Andrews T, Sullivan KE. Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev. 2003;16(4):597–621.  https://doi.org/10.1128/CMR.16.4.597–621.2003.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bluestone JA, Bour-Jordan H, Cheng M, Anderson M. T cells in the control of organ-specific autoimmunity. J Clin Invest. 2015;125(6):2250–60.  https://doi.org/10.1172/JCI78089.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Chesné J, Faouzi Braza F, Mahay G, et al. IL-17 in severe asthma. Where do we stand? Am J Respir Crit Care Med. 2014;190(10):1094–101.  https://doi.org/10.1164/rccm.201405-0859PP.CrossRefPubMedGoogle Scholar
  4. Chiba S, Ikushima H, Ueki H, et al. Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses. elife. 2014;3:e04177.  https://doi.org/10.7554/eLife.04177.001.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Cortez-Retamozoa V, Etzrodta M, Newton A, et al. Origins of tumor-associated macrophages and neutrophils. PNAS. 2012;109(7):2491–6.  https://doi.org/10.1073/pnas.1113744109.CrossRefGoogle Scholar
  6. Elliott I, Venkatesan P. Infections in the secondary immunocompromised host. In: eLS. Chichester: John Wiley & Sons Ltd; 2015.  https://doi.org/10.1002/9780470015902.a0002224.pub.CrossRefGoogle Scholar
  7. Fulop T, Witkowski JM, Pawelec G, Cohen Alan C, Larbi A. On the immunological theory of aging. In: Robert L, Fulop T, editors. Aging: facts and theories. Interdiscipl Top Gerontol, vol. 39. Basel: Karger; 2014. p. 163–76.  https://doi.org/10.1159/000358904.CrossRefGoogle Scholar
  8. Hasegawa T, Uga H, Mori A, Kurata H. Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma. Eur Cytokine Netw. 2017;28(1):8–18.  https://doi.org/10.1684/ecn.2017.0390.CrossRefPubMedGoogle Scholar
  9. Hernandez C, Huebener P, Schwabe RF. Damage-associated molecular patterns in cancer: a double-edged sword. Oncogene. 2016;35(46):5931–41.  https://doi.org/10.1038/onc.2016.104.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Jensen-Jarolim E, Mechtcheriakova D, Pali-Schoell I. Chapter 10. The targets of IgE: Allergen-Associated and Tumor-Associated Molecular Patterns. In: Penichet ML, Jensen-Jarolim E, editors. Cancer and IgE. Vienna: Springer Science+Business Media; 2010. p. 231–54.  https://doi.org/10.1007/978-1-60761-451-7_10.CrossRefGoogle Scholar
  11. Klimov VV, Salikova TI, Koshkarova NS, et al. IL4, IFNγ, IL10 and IL17 values in skin exudates in atopic dermatitis with mutation 2282del4 in the filaggrin gene. In: 14th International Congress of Immunology. International Immunology, vol. 22. Kobe: IUIS; 2010. p. 66–7.Google Scholar
  12. Kutikhin AG, Yuzhalin AE. Pattern recognition receptors and cancer. Font Immunol. 2015;6:481.  https://doi.org/10.3389/fimmu.2015.00481.CrossRefGoogle Scholar
  13. Mittal D, Gubin MM, Schreiber RD, Smyth MJ. New insights into cancer immunoediting and its three component phases - elimination, equilibrium and escape. Curr Opin Immunol. 2014;27:16–25.  https://doi.org/10.1016/j.coi.2014.01.004.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Puebla LEJ. Chapter 6. Fungal infections in immunosuppressed patients. In: Metodiev K, editor. Immunodeficiency. London: InTech; 2012. p. 149–76.  https://doi.org/10.5772/51512.CrossRefGoogle Scholar
  15. Rao VK, Oliveira JB. How I treat autoimmune lymphoproliferative syndrome. Blood. 2011;118(22):5741–51.  https://doi.org/10.1182/blood-2011-07-325217.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Sánchez-Fueyo A, Strom TB. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology. 2011;140(1):1–24.  https://doi.org/10.1053/j.gastro.2010.10.059.CrossRefGoogle Scholar
  17. Seitz R. Human Immunodeficiency Virus (HIV). Transfus Med Hemother. 2016;43:203–22.  https://doi.org/10.1159/000445852.CrossRefGoogle Scholar
  18. Seyfried TN. Cancer as a mitochondrial metabolic disease. Front Cell Dev Biol. 2015;3(43):1–12.  https://doi.org/10.3389/fcell.2015.00043.CrossRefGoogle Scholar
  19. Wahren-Herlenius M, Dorner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet. 2013;382(9894):819–31.  https://doi.org/10.1016/S0140-6736(13)60954-X.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Vladimir V. Klimov
    • 1
  1. 1.Clinical Immunology and Allergy DepartmentSiberian State Medical UniversityTomskRussia

Personalised recommendations